|

Fezolinetant Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: ESN364;, VEOZAH™

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

  • Yale University1
  • University of Vermont1
  • Astellas Pharma Global Development, Inc.1

Indications

  • Cancer3
  • Breast Cancer2
  • Hot Flashes1
  • Prostate CA1
  • Androgen Deprivation Therapy1

Other1 trial

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Phase 3

New Haven, Connecticut1 trial

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Yale University

Phase 2

Burlington, Vermont1 trial

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

University of Vermont Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.